Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on July 26, 2021.

From July 25, 2021 to September 30, 2021, the company has repurchased 8,679,907 shares, representing 0.78% for CNY 234.51 million. With this, the company has completed the repurchase of 8,679,907 shares, representing 0.78% for CNY 234.51 million under the buyback announced on July 26, 2021.